STINGとリンフォトキシンβ受容体の同時活性化により,三次リンパ性構造のB細胞反応が誘発され,抗腫瘍免疫が強化される
Junko Sawada1, Yasuhiro Kikuchi1, Maxwell Duah1
1Cancer and Blood Disorders Institute, Institute for Fundamental Biomedical Research, and Department of Surgery, Johns Hopkins All Children's Hospital, and Department of Orthopaedic Surgery, Johns Hopkins University School of Medicine, St. Petersburg, FL, USA.
Nature immunology
|September 2, 2025
まとめ
STINGとリンパ毒素β受容体 (LTβR) の経路を同時に活性化すると,抗腫瘍免疫を強化し,長期的な生存を改善する三次リンパ性構造 (TLS) が形成されます. STINGの活性化だけでは,これらの治療効果は得られなかった.
科学分野:
- 免疫学
- 癌 生物学
- 腫瘍学
背景:
- B細胞に富んだ三次リンパ性構造 (TLS) は,がんの予後と免疫療法への反応の改善と相関しています.
- STINGやリンパ毒素β受容体 (LTβR) のシグナル伝達のような先天的な免疫経路は,免疫反応において極めて重要です.
研究 の 目的:
- 抗腫瘍免疫とTLS形成に対するSTINGとLTβRの結合効果を調査する.
- 臨床前がんモデルにおけるSTINGとLTβRの共同活性化の治療の可能性を評価する.
主な方法:
- マウスがんモデルでSTINGとLTβR経路を同時に活性化するためにアゴニストを使用した.
- 評価された腫瘍抑制,TLSの発達,免疫細胞の浸透 (CD8+,CD4+ T細胞,B細胞),および長期生存.
- 分析されたB細胞の成熟,血細胞の生成,Tヘルパー細胞のバランス (TH2/TH17).
主要な成果:
- STINGとLTβRの結合活性化により,CD8+T細胞依存性腫瘍抑制が促進され,生殖中心のようなB細胞反応による機能的TLSが誘発された.
- この二重活性化により,腫瘍の再発に対する有効な免疫と,ネオアジュバントの環境での長期生存が可能になりました.
- STINGの活性化だけではTLS誘発や長期的な治療効果には不十分であったが,LTβRとの組み合わせはTLS,B細胞成熟,T細胞応答,および体内/細胞免疫を強化した.
結論:
- STINGとLTβR経路の同時活性化は,機能的なTLSと強力な抗腫瘍免疫を生み出すための有望な戦略です.
- このアプローチはB細胞の成熟とT細胞の反応を向上させ 免疫バランスを効率的な腫瘍制御へと転換させます
- STINGとリンパ毒素経路の両方を標的にすることで 癌治療の新たな治療法が生まれます
関連する概念動画
B Cell Activation and Differentiation
5.5K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
5.5K
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
Cells of the Adaptive Immune Response
4.0K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
4.0K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Special Features of Adaptive Immunity
1.1K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
1.1K
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659


